BioVentureHub 2.0
| Reference number | |
| Coordinator | AstraZeneca BioVentureHub AB |
| Funding from Vinnova | SEK 20 718 035 |
| Project duration | January 2020 - December 2024 |
| Status | Ongoing |
| Venture | 2017-01599-en |
Purpose and goal
** Denna text är maskinöversatt ** AstraZeneca BioVentureHub 2.0 will continue the expansion of BioVentureHub with the goal of becoming a world-leading ecosystem within Life Science. BioVentureHub 2.0 will offer additional access to AZ´s infrastructure and builds on the unique Swedish collaboration climate. By increasingly contributing to collaboration across various industrial sectors of relevance to the future of Life Science innovation, BioVentureHub contributes to continued benefits for industry, healthcare and patients.
Expected effects and result
** Denna text är maskinöversatt ** Through the BVH ecosystem, catalyze collaborations and growth within Swedish Life Science through increased degree of collaboration between industry, small companies and academia, thereby increasing the density of competence relevant to increased growth and innovation. Furthermore, we want to collaborate with GoCo HIC to create a world-unique Life Science environment in the area around AstraZeneca.
Planned approach and implementation
** Denna text är maskinöversatt ** Add another house, which means we can expand our operations in accordance with our current strategy. We plan to strengthen the ecosystem through cross-sector collaborations with other industries such as ICT. Increased accessibility of infrastructure such as Lab4Life access. Strengthen the appeal of digital health through cross-sector industrial collaboration. Furthermore, we will expand the team around BVH to handle support to the companies in BVH.